Today’s Research Reports on Trending Tickers: Exact Sciences and Exelixis

NEW YORK, NY / ACCESSWIRE / April 10, 2018 / U.S. markets rallied in early trading Monday on the strength of technology stocks and the easing of trade relations between the U.S. and China. However, most of the day’s gains were lost in the final minutes of trading following news that FBI raided President Trump’s personal lawyer’s office. The Dow Jones Industrial Average gained 0.19 percent to close at 23,979.10, while the S&P 500 Index rose 0.33 percent to close at 2,613.16. The tech-heavy Nasdaq Composite Index jumped 0.51 percent to close at 6,950.34. All of the FANG (Facebook, Amazon, Netflix and Google’s parent company Alphabet) saw gains of over 1.0 percent.

“Right now, investors are learning how Trump operates in negotiating. He made an initial stance, trying to get the other side to cave in a bit, but recent commentary toward China has been more reserved and friendly, which is why we’re higher today,” said Sam Stovall, chief investment strategist of U.S. equity strategy at CFRA, according to CNBC.

RDI Initiates Coverage on:

Exact Sciences Corporation
https://rdinvesting.com/news/?ticker=EXAS

Exelixis, Inc.
https://rdinvesting.com/news/?ticker=EXEL

Exact Sciences’ stock jumped 6.63% Monday, to close the day at $40.35. The stock recorded a trading volume of 2,211,517 shares, which was below its three months average volume of 2,964,144 shares. In the last year, Exact Sciences’ shares have traded in a range of 22.46 – 63.60. The share price has gained 79.65% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $45.90 is below its 200-day moving average of $50.45. Shares of Exact Sciences have fallen roughly 22.63 percent in the past month and are down 23.20 percent year-to-date.

Access RDI’s Exact Sciences Corporation Research Report at:
https://rdinvesting.com/news/?ticker=EXAS

On Monday, shares of Exelixis recorded a trading volume of 8,891,192 shares, which was above the three months average volume of 2,985,116 shares. The stock ended the day 6.73% lower at 19.67. The stock is currently trading 39.48% below its 52-week high with a 52-week trading range of 18.03 – 32.50. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $24.59 is below its 200-day moving average of $26.78. Shares of Exelixis are trading at a Price to Earnings ratio of 39.90. Shares of Exelixis have fallen roughly 19.81 percent in the past month and are down 35.30 percent year-to-date.

Access RDI’s Exelixis, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EXEL

Our Actionable Research on Exact Sciences Corporation (NASDAQ:EXAS) and Exelixis, Inc. (NASDAQ:EXEL) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute

SOURCE: RDInvesting.com

ReleaseID: 495646